Related Experiment Video

Updated: Aug 6, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Novel approaches using natural killer cells in cancer therapy

Garnet Suck1

  • 1Division of Biomedical Sciences, Johns Hopkins in Singapore, 31 Biopolis Way, #02-01 The Nanos, Singapore, Singapore. garnet@bms.jhmi.edu

Seminars in Cancer Biology
|August 18, 2006
PubMed

Insights

Natural killer (NK) cell therapies show promise for treating various cancers. Researchers are exploring novel approaches, including alloreactive NK cells and targeted therapies, to improve patient survival and reduce side effects.

Area of Science:

  • Immunology
  • Oncology
  • Cell therapy

Background:

  • Natural killer (NK) cells are increasingly recognized for their therapeutic potential in oncology.
  • Traditional immunotherapies like lymphokine-activated killer (LAK) cells and cytokine treatments have limitations.
  • Alloreactive NK cells have demonstrated promising outcomes in specific clinical scenarios.

Purpose of the Study:

  • To review emerging strategies for applying NK cells in cancer therapy.
  • To highlight novel clinical approaches overcoming limitations of earlier treatments.
  • To discuss advancements in understanding NK cell cytotoxicity for improved cancer treatments.

Main Methods:

  • Review of current clinical approaches utilizing NK cells for cancer treatment.
  • Evaluation of strategies involving alloreactive NK cells.
  • Assessment of therapies targeting heat-shock protein 70 (Hsp70) expressing tumors with autologous NK cells.
  • Consideration of NK cell line NK-92 for enhanced cytolytic activity.

Main Results:

  • Alloreactive NK cells have shown remarkable results, including improved survival and amelioration of graft-versus-host disease.
  • Pre-stimulated autologous NK cells targeting Hsp70+ tumors are under clinical evaluation.
  • The NK-92 cell line demonstrates enhanced cytolytic activity and is being investigated.

Conclusions:

  • Emerging NK cell-based therapies offer new avenues for treating a broad range of malignancies.
  • Further research into NK cell cytotoxicity mechanisms is crucial for optimizing clinical applications.
  • NK cell therapy represents a promising frontier in cancer treatment.

More Related Videos

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line11:02

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...